Viewing Study NCT01385956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2026-02-22 @ 3:56 PM
Study NCT ID: NCT01385956
Status: COMPLETED
Last Update Posted: 2020-09-28
First Post: 2011-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: SOM 230 and Gemcitabine in Advanced Pancreatic Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic View
None locally advanced View
None combination therapy View
None dose escalation View
None epithelial cancer View
None adenocarcinoma View
None exocrine pancreas View